The 2019 novel coronavirus disease (COVID-19) pandemic has dramatically impacted numerous health and economic fronts. Due to the stay-at-home mandate and practice of physical distancing, nearly all preventive care measures have been halted, including colorectal cancer (CRC) screening. The health consequences of this temporary suspension are of great concern, particularly for underserved populations, who experience substantial CRC-related disparities. In this Commentary, we describe challenges and opportunities to deliver COVID-adapted CRC screening to medically underserved populations receiving care in community health centers (CHC). This perspective is based on key informant interviews with CHC medical directors, teleconference discussions, and strategic planning assessments. To address the unprecedented challenges created by the COVID-19 pandemic, we identify two broad calls to action: 1) Invest in CHCs now; and 2) Support equitable and adaptable telehealth solutions now and in the future. We also recommend four CRC-specific calls to action: Establish COVID-adapted best practices to implement mailed fecal immunochemical test (FIT) programs; Implement grassroots advocacy to identify community gastroenterologists who commit to performing colonoscopies for CHC patients; Assess cancer prevention priorities among individuals in underserved communities; and Assess regional CRC screening and follow-up barriers and solutions. The COVID-19 pandemic may further exacerbate existing CRC screening disparities in underserved individuals. This will likely lead to delayed diagnosis, a shift to later stage disease, and increased CRC deaths. To prevent this from happening, we call for timely action and a commitment to address the current extraordinary CRC screening challenges for vulnerable populations.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please email: